Arrowstreet Capital, Limited Partnership Becton Dickinson & CO Transaction History

Arrowstreet Capital, Limited Partnership

$148 Billion
Q3 2025

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Becton Dickinson & CO stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 370,008 shares of BDX stock, worth $70.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

370,008

Previous 197,345 87.49%

Holding current value

$70.7 Million

Previous $34 Million 103.74%

% of portfolio

0.05%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$172.41 - $199.66 $29.8 Million - $34.5 Million	172,663 Added 87.49%	370,008 $69.3 Million
Q2 2025 Aug 13, 2025	BUY	$165.15 - $226.42 $32.6 Million - $44.7 Million	197,345 New	197,345 $34 Million
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $3.25 Million - $3.56 Million	-14,680 Reduced 4.85%	287,725 $69.4 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $27.5 Million - $30.1 Million	-122,219 Reduced 28.78%	302,405 $70.7 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $48.6 Million - $51.6 Million	-208,272 Reduced 32.91%	424,624 $105 Million

Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $5.3 Million - $6.1 Million	22,817 Added 3.74%	632,896 $154 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $88.6 Million - $98.6 Million	-347,592 Reduced 36.3%	610,079 $158 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $157 Million - $174 Million	-657,626 Reduced 40.71%	957,671 $253 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $6.99 Million - $7.89 Million	-30,428 Reduced 1.85%	1,615,297 $400 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $144 Million - $169 Million	659,013 Added 66.79%	1,645,725 $419 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $16.1 Million - $83.4 Million	315,534 Added 47.01%	986,712 $220 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $54.3 Million - $63.8 Million	-231,520 Reduced 25.65%	671,178 $165 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $5.56 Million - $6.17 Million	-22,820 Reduced 2.47%	902,698 $240 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $151 Million - $165 Million	657,851 Added 245.77%	925,518 $233 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $36.1 Million - $39.8 Million	155,161 Added 137.91%	267,667 $65.8 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $791,010 - $865,572	-3,400 Reduced 2.93%	112,506 $27.4 Million
Q1 2021 May 14, 2021	BUY	$232.09 - $256.88 $13.3 Million - $14.8 Million	57,500 Added 98.45%	115,906 $28.2 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $9.47 Million - $10.5 Million	-42,654 Reduced 42.21%	58,406 $14.6 Million
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $18.3 Million - $23.5 Million	84,965 Added 527.9%	101,060 $23.5 Million
Q2 2020 Aug 12, 2020	SELL	$219.9 - $263.41 $16.2 Million - $19.4 Million	-73,705 Reduced 82.08%	16,095 $3.85 Million
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $17.6 Million - $25.1 Million	89,800 New	89,800 $20.6 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $7.58 Million - $9.13 Million	-36,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $7.12 Million - $8.98 Million	34,800 Added 1740.0%	36,800 $8.29 Million
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $466,140 - $512,000	2,000 New	2,000 $522,000
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $2.77 Million - $3.24 Million	-13,500 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $2.55 Million - $3.01 Million	13,500	13,500 $2.89 Million

Others Institutions Holding BDX

# of Institutions

1,718

Shares Held

257M

Call Options Held

1.01M

Put Options Held

544K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Becton Dickinson & CO Transaction History